JNCI Journal of the National Cancer Institute

REVIEWS

T Deguchi, M Yang, and Y Kawada

Micrometastasis of prostate cancer to lymph nodes: detection by means of reverse transcription-polymerase chain reaction
J. Natl. Cancer Inst. 1997 89: 1471; doi:10.1093/jnci/89.20.1471 [PDF]  

HS Chan and V Ling

Anti-P-glycoprotein antibody C219 cross-reactivity with c-erbB2 protein: diagnostic and clinical implications
J. Natl. Cancer Inst. 1997 89: 1473; doi:10.1093/jnci/89.20.1473 [PDF]  

FJ Kaye

Can p53 status resolve paradoxes between human and non-human retinoblastoma models?
J. Natl. Cancer Inst. 1997 89: 1476; doi:10.1093/jnci/89.20.1476 [PDF]  

WB Ershler and DL Longo

Aging and cancer: issues of basic and clinical science
J. Natl. Cancer Inst. 1997 89: 1489; doi:10.1093/jnci/89.20.1489 [Abstract] [PDF]  

C Porta, M Moroni, E Bobbio-Pallavicini, C Tinelli, and M Regazzi-Bonora

Nitrate plasma level as a marker of nitric oxide production after subcutaneous interleukin 2 immunotherapy
J. Natl. Cancer Inst. 1997 89: 1545; doi:10.1093/jnci/89.20.1545 [PDF]  

NEWS

S Jenks

Genes to order: regulators struggle against future abuses
J. Natl. Cancer Inst. 1997 89: 1478.  

A Saphir

Jekyll and Hyde: a new license for thalidomide?
J. Natl. Cancer Inst. 1997 89: 1480.  

C McNeil

Vitamins during pregnancy linked to lower risk of childhood brain tumors
J. Natl. Cancer Inst. 1997 89: 1481.  

NJ Nelson

Solutions bring new problems: secondary cancers are a risk for some survivors
J. Natl. Cancer Inst. 1997 89: 1483.  

J McCann

Texas center studies research alternative treatments
J. Natl. Cancer Inst. 1997 89: 1485.  

ARTICLES

AC Ferrari, NN Stone, JN Eyler, M Gao, J Mandeli, P Unger, RE Gallagher, and R Stock

Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer
J. Natl. Cancer Inst. 1997 89: 1498; doi:10.1093/jnci/89.20.1498 [Abstract] [PDF]  

K Wosikowski, D Schuurhuis, K Johnson, KD Paull, TG Myers, JN Weinstein, and SE Bates

Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns
J. Natl. Cancer Inst. 1997 89: 1505; doi:10.1093/jnci/89.20.1505 [Abstract] [PDF]  

MM Madeleine, JR Daling, JJ Carter, GC Wipf, SM Schwartz, B McKnight, RJ Kurman, AM Beckmann, ME Hagensee, and DA Galloway

Cofactors with human papillomavirus in a population-based study of vulvar cancer [published erratum appears in J Natl Cancer Inst 1997 Dec 17;89(24):1896]
J. Natl. Cancer Inst. 1997 89: 1516; doi:10.1093/jnci/89.20.1516 [Abstract] [PDF]  

B Liu, D Sun, W Xia, MC Hung, and D Yu

Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1)
J. Natl. Cancer Inst. 1997 89: 1524; doi:10.1093/jnci/89.20.1524 [Abstract] [PDF]  

CL Schlamp, GL Poulsen, TM Nork, and RW Nickells

Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells
J. Natl. Cancer Inst. 1997 89: 1530; doi:10.1093/jnci/89.20.1530 [Abstract] [PDF]  

MM de las Alas, S Aebi, D Fink, SB Howell, and G Los

Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance
J. Natl. Cancer Inst. 1997 89: 1537; doi:10.1093/jnci/89.20.1537 [Abstract] [PDF]  

MA Smith, T Chen, and R Simon

Age-specific incidence of acute lymphoblastic leukemia in U.S. children: in utero initiation model
J. Natl. Cancer Inst. 1997 89: 1542; doi:10.1093/jnci/89.20.1542 [PDF]  

CORRESPONDENCE

CM Schehl and GK Ostrander

Identification of BRCA1 germline mutation, 797delAA, in a Japanese breast-ovarian cancer patient
J. Natl. Cancer Inst. 1997 89: 1547; doi:10.1093/jnci/89.20.1547 [PDF]  

M Napoli

Re: Oncologists judge themselves the best judges of cancer treatments
J. Natl. Cancer Inst. 1997 89: 1548; doi:10.1093/jnci/89.20.1548 [PDF]  

IC Haznedaroglu, Y Buyukasik, M Benekli, and IH Gullu

Proposed modification of the "real Working" classification of lymphoid neoplasms
J. Natl. Cancer Inst. 1997 89: 1546; doi:10.1093/jnci/89.20.1546a [PDF]  

R Sridhara

Re: prediction of carboplatin clearance from standard morphological and biological patient characteristics
J. Natl. Cancer Inst. 1997 89: 1546.  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.